Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Jennifer Woyach
CLL trials
Jing Yang
Myeloma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Brian Dalton
DNA mutations and myeloid cancers
Siegfried Janz
Myeloma immunotherapy
Peter Klein
MDS
Peter Croucher
Multiple Myeloma
Logan Spector
childhood leukemia epidimiology
Fahmin Basher
transplant and GvHD
Adam Olszewski
Follicular and marginal zone lymphoma
Reina Takeda
AML
Steven Treon
Lymphomas and Waldenstrom's
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Catherine Diefenbach
DLBCL immunology
Lev Kats
myeloma and epigenetics
Daniel Lucas
bone marrow and leukemia biology
Daniel Pollyea
AML
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Kimberly Stegmaier
childhood blood cancers
Jolanta Grembecka
leukemia therapeutics
Catherine Smith
leukemia
Robert Orlowski
(Smoldering) Multiple Myeloma
Jennifer Trowbridge
aging and leukemia
Alex Kentsis
pediatric leukemias
Ann-Kathrin Eisfeld
Racial diversity in AML
Eirini Papapetrou
blood cancer stem cells
Srividya Swaminathan
pediatric, immunotherapy
H. Irene Su
Equity in Access
Grant Challen
preleukemia, leukemia
Catherine Bollard
pediatric blood cancers and immunotherapy
Alfred Garfall
myeloma immunotherapy
Anouchka Laurent
T-cell lymphoma
Tak Mak
Immunotherapy
Pooja Khandelwal
bone marrow transplantation
Wendy Béguelin
follicular lymphoma
Ana Vujovic
AML
Randall Davis
CLL
Nicolas Nassar
pediatric leukemia
Marco Ruella
Immunotherapy for T-cell lymphoma
Rizwan Romee
Immunotherapy
Jennifer Amengual
lymphomas after transplant
ImCheck Therapeutics
immunotherapy, AML
Thomas Koehnke
leukemia
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Jonathan Licht
DNA biology, myeloma
Marina Konopleva
MDS/AML metabolism
Nirav Shah
CAR-T for lymphoma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Sam Butterworth
CMML
Steven Park
follicular lymphoma
Yoke Seng Lee
AML
George Vassiliou
Leukemia Prevention
Philippe Armand
follicular lymphoma
Manyi Wei
acute megakaryoblastic leukemia
Bruno Paiva
smoldering myeloma
Ruben Carrasco
Myeloma
Lawrence Boise
CART and myeloma
Caroline Arber
myeloma CAR-T
Anushree Vichare
Equity in Access
Catriona Jamieson
cancer stem cell biology
Coleman Lindsley
AML/MDS
Urvi Shah
Diet and myeloma
Mark Hamilton
DLBCL and CAR-T
Sriram Sundaravel
AML stem cells
Sahand Hormoz
MPN
Bailee Kain
AML and African ancestry
Jaehyuk Choi
T-cell lymphoma
Christian Steidl
B-cell lymphomas
Stacie Dusetzina
Equity in Access
William Matsui
Myeloma
Inhye Ahn
CLL
Suzanne Lentzsch
Myeloma
Jayna Mistry
aging and leukemias
Jeffrey Magee
pediatric AML
Anthony Letai
improving CAR-T
Marc Seifert
Hairy cell leukemia
Jun Qi
Myeloma
Yan Liu
MDS
Paul Beavis
immunotherapy in myeloma
Liran Shlush
pre-leukemia
Helen Parsons
Equity in Access
Takeshi Sugio
T-cell lymphoma
Luca Busino
DLBCL
Kirk Schultz
pediatric transplantation
Venkata Lokesh Battula
immunotherapy and AML
Roland Walter
Antibody-based AML therapies
Andrew Lane
BPDCN
Jenny Wang
AML
Dimericon Therapeutics
dimericons, blood cancer
Jing Fu
myeloma
Jianhua Yu
myeloma immunotherapy
Christopher Booth
BPDCN
Neha Mehta-Shah
T-cell lymphoma
Thomas LeBlanc
palliative care
Jonas Jutzi
myeloproliferative neoplasms
Julia Maxson
AML
Siddhartha Jaiswal
preleukemia
Armin Rashidi
gut bacteria and transplant success
Noemí Puig Morón
Myeloma
Mark Murakami
follicular lymphoma
Timothy Graubert
AML and MDS biology
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Saar Gill
AML immunotherapy
Carl June
CAR T immunotherapy
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Madhav Dhodapkar
multiple myeloma immunotherapy
Jeremy Baeten
AML
Carma Bylund
Equity in Access
Affimed
immunotherapy, HL, PTCL
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Dan Landau
cancer evolution biology
Tomasz Skorski
myeloproliferative neoplasms, AML
Sham Mailankody
Myeloma immunotherapy clinical trials
Trent Hall
MDS
Kathleen Sakamoto
pediatric AML
Keisuke Ito
blood cancer stem cells and MDS metabolism
Simona Colla
Myeloma biology
Lindsey Montefiori
pediatric leukemia
Tycel Phillips
Mantle Cell Lymphoma
Bingyi Chen
AML immunotherapy
Carl Allen
pediatric blood cancers
John Crispino
myelofibrosis, pediatric leukemia and Downs
Faron Pharmaceuticals
immunotherapy, MDS
Gianpietro Dotti
CAR T and AML
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Amit Verma
AML/MDS
John DiPersio
trispecific antibody for AML and MDS
Margaret Shipp
lymphoma biology
Kerry Rogers
CLL
James Rubenstein
Lymphoma of the Central Nervous System
Matthew Frank
Lymphoma CART therapy
Lucy Godley
preleukemia
Britta Will
Leukemia and pre-leukemia
Justine Kahn
pediatric leukemia and lymphoma
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Jessica Stewart
Epstein-barr virus and lymphomas
Bing Carter
p53 mutant AML
Cailin Collins
Leukemia and pre-leukemia
Matteo Bellone
Smoldering multiple myeloma
Michael Wang
Mantle Cell Lymphoma
Ricky Johnstone
lymphoma and myeloma
Julia Paczkowska
immunobiology of Hodgkin's disease
Oreofe Odejide
Equity in Access
Teresa Palomero
Peripheral T-cell Lymphoma
Paolo Strati
Non-Hodgkin Lymphoma
Robert Soiffer
transplantation
Lori Muffly
Equity in Access
Yiman Liu
Epigenetics and leukemia
Brian Walker
smoldering myeloma, MGUS
Richard Lock
T-ALL
Jonathon Cohen
lymphoma clinical trial access in Georgia
Riccardo Dalla-Favera
lymphoma (DLBCL)
Michael Keller
COVID-19, immunotherapy
Hong Wen
AML
Kura Oncology
MLL leukemia, AML
Suman Paul
T cell cancers and immunotherapy
Christopher Porter
Leukemia, lymphoma
Enterome
vaccine, FL, MZL
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Jeetayu Biswas
splicing in myeloid diseases
Sergei Doulatov
Leukemias
Tanya Siddiqi
clinical trial access
Caron Jacobson
lymphoma and immunotherapy
Markus Muschen
leukemia and lymphoma biology
Alieen Rowan
Adult T cell leukemia/lymphoma
Caner Saygin
T-ALL
Soheil Meshinchi
pediatric AML
Jake Shortt
precision therapy for aggressive lymphomas
Constellation Pharmaceuticals
myeloproliferative neoplasms
Roberta Zappasodi
lymphoma, immunotherapy
Michaela Reagan
Multiple Myeloma
Omar Abdel-Wahab
Hairy cell leukemia
Koichi Takahashi
AML/MDS
Sarah Tasian
pediatric leukemias
Thomas Kipps
Hairy Cell Leukemia
Jean Koff
Disparities in DLBCL
Nicoletta Cieri
AML and transplantation
Hao Jiang
DNA biology and leukemia
Megan McNerney
AML/MDS
Rajni Kumari
AML
Qingyu Luo
BPDCN
Stephen Nimer
myeloid cancer biology
Nataly Cruz-Rodriguez
T-ALL and metabolism
Christine Zhang
AML
Daniel Thomas
Myelofibrosis
Qing Yi
Novel CAR-T
Shazia Nakhoda
Equity in Access
BioInvent International
immunotherapy, indolent NHL, CTCL
Christian Marinaccio
MLL leukemias
Kasey Leger
pediatric blood cancers
Piers Patten
COVID-19
Yubin Zhou
peripheral T cell lymphoma
Jalpa Doshi
Equity in Access
Michael Green
lymphoma biology
Elliot Stieglitz
CMML
Meng Li
Equity in Access
Adi Nagler
Bronchiolitis obliterans after transplant
Solu Therapeutics
immunotherapy, CMML
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Nizar Bahlis
Myeloma immunotherapy
Yibin Yang
Lymphoma
Adam de Smith
pediatric ALL and Down Syndrome
Nicola Vannini
Aging and CAR-T success
Steven Horwitz
T-cell lymphomas
Daisuke Nakada
preleukemia, leukemia
F. Lennie Wong
Equity in Access
Dane Vassiliadis
blood cancer biology
John Leonard
lymphoma research
Jianguo Tao
Mantle Cell Lymphoma
Taishi Yonezawa
AML
Xu Ji
Equity in Access
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Mark Dawson
B-ALL and CAR-T resistance
Grzegorz Nowakowski
Clinical trial access
Courtney Jones
AML metabolism
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Pietro Genovese
transplant and AML
Frederick Locke
lymphoma and immunotherapy
Gaurav Goyal
Erdheim-Chester Disease
Fenghuang Zhan
Myeloma and bone disease
Ronald Levy
immunotherapies, COVID-19
Shannon Maude
Immunotherapy for ALL
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Martin Dreyling
Mantle Cell Lymphoma
Nitin Jain
CLL
Paolo Caimi
CAR-T clinical trial for CLL
Joachim Yahalom
Lymphoma
Eric Pietras
AML
Leandro Cerchietti
DLBCL
Ravi Bhatia
transplantation
Rachel Mersfelder
AMKL
Mendel Goldfinger
MDS/AML trials for the elderly
George Daley
"off-the-shelf" CAR-T and CAR-NK
Courtney DiNardo
clinical trials, AML
Michael Kharas
leukemia
Tyler Parsons
MPN and AML
Stephen Gottschalk
pediatric leukemia and CAR-T
Raymond Mailhot
Equity in Access
Eric Padron
CMML
Daniel Herranz
T-ALL
Sigurður Kristinsson
Smoldering myeloma
Sheng Li
Aging and AML
Enrico Tiacci
Hairy cell leukemia
Maximilian Stahl
AML immunotherapy
Rgenta Therapeutics
RNA-targeting, blood cancer
Huda Salman
CMML
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Eugenio Morelli
Myeloma
Liling Wan
AML
Wendy Stock
T-cell ALL
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Ravindra Majeti
preleukemia, AML
Craig Jordan
AML
Christopher Flowers
clinical trial access
Alexey Danilov
lymphoma
Ari Melnick
epigenetics and lymphoma
Mala Shanmugam
myeloma
Michael Savona
MDS and leukemia
Rong Lu
preleukemia, leukemia